These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38436491)

  • 41. Optimal blood pressure target and measurement in patients with chronic kidney disease.
    Kim CS; Choi HS; Bae EH; Kim SW; Ma SK
    Korean J Intern Med; 2019 Nov; 34(6):1181-1187. PubMed ID: 31189302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Variations in 24-Hour BP Profiles in Cohorts of Patients with Kidney Disease around the World: The I-DARE Study.
    Drawz PE; Brown R; De Nicola L; Fujii N; Gabbai FB; Gassman J; He J; Iimuro S; Lash J; Minutolo R; Phillips RA; Rudser K; Ruilope L; Steigerwalt S; Townsend RR; Xie D; Rahman M;
    Clin J Am Soc Nephrol; 2018 Sep; 13(9):1348-1357. PubMed ID: 29976600
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is Blood Pressure Improving in Children With Chronic Kidney Disease? A Period Analysis.
    Barletta GM; Pierce C; Mitsnefes M; Samuels J; Warady BA; Furth S; Flynn J
    Hypertension; 2018 Mar; 71(3):444-450. PubMed ID: 29295853
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care.
    Fraser SD; Roderick PJ; McIntyre NJ; Harris S; McIntyre CW; Fluck RJ; Taal MW
    BMC Fam Pract; 2013 Jun; 14():88. PubMed ID: 23800117
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care.
    de Beus E; van der Sande NGC; Bots ML; Spiering W; Voskuil M; Visseren FLJ; Blankestijn PJ
    BMJ Open; 2017 Sep; 7(9):e016692. PubMed ID: 28882918
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease.
    Crespo JJ; Piñeiro L; Otero A; Castiñeira C; Ríos MT; Regueiro A; Mojón A; Lorenzo S; Ayala DE; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):159-75. PubMed ID: 23098134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antihypertensive therapy prescribing patterns and correlates of blood pressure control among hypertensive patients with chronic kidney disease.
    Magvanjav O; Cooper-DeHoff RM; McDonough CW; Gong Y; Segal MS; Hogan WR; Johnson JA
    J Clin Hypertens (Greenwich); 2019 Jan; 21(1):91-101. PubMed ID: 30427124
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characteristics and Predictors of Apparent Treatment Resistant Hypertension in Real-World Populations Using Electronic Health Record-Based Data.
    Jafari E; Cooper-DeHoff RM; Effron MB; Hogan WR; McDonough CW
    medRxiv; 2023 May; ():. PubMed ID: 37205447
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis.
    Scalise F; Sole A; Singh G; Sorropago A; Sorropago G; Ballabeni C; Maccario M; Vettoretti S; Grassi G; Mancia G
    J Hypertens; 2020 May; 38(5):936-942. PubMed ID: 31990900
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of Blood Pressure Control on Long-Term Risk of End-Stage Renal Disease and Death Among Subgroups of Patients With Chronic Kidney Disease.
    Ku E; Sarnak MJ; Toto R; McCulloch CE; Lin F; Smogorzewski M; Hsu CY
    J Am Heart Assoc; 2019 Aug; 8(16):e012749. PubMed ID: 31411082
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apparent Treatment-Resistant Hypertension Assessed by Office and Ambulatory Blood Pressure in Chronic Kidney Disease-A Report from the Chronic Renal Insufficiency Cohort Study.
    Thomas G; Felts J; Brecklin CS; Chen J; Drawz PE; Lustigova E; Mehta R; Miller ER; Sozio SM; Weir MR; Xie D; Wang X; Rahman M
    Kidney360; 2020 Aug; 1(8):810-818. PubMed ID: 34308363
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of Prediabetes on the Effects of Intensive Systolic Blood Pressure Control on Kidney Events.
    Rathi N; Whelton PK; Chertow GM; Cushman WC; Cheung AK; Wei G; Boucher R; Kimmel PL; Bress AP; Kramer HJ; Al-Marji C; Greene T; Beddhu S
    Am J Hypertens; 2019 Nov; 32(12):1170-1177. PubMed ID: 31257407
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association Between Sleep Apnea and Blood Pressure Control Among Blacks.
    Johnson DA; Thomas SJ; Abdalla M; Guo N; Yano Y; Rueschman M; Tanner RM; Mittleman MA; Calhoun DA; Wilson JG; Muntner P; Redline S
    Circulation; 2019 Mar; 139(10):1275-1284. PubMed ID: 30586763
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Relationship of polymedication in controlling blood pressure: compliance, persistence, costs and incidence of new cardiovascular events].
    Sicras Mainar A; Muñoz Ortí G; Font Ramos B; Majós Oró N; Navarro Artieda R; Ibáñez Nolla J
    Med Clin (Barc); 2013 Jul; 141(2):53-61. PubMed ID: 22766057
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Associations of Systolic Blood Pressure With Incident CKD G3-G5: A Cohort Study of South Korean Adults.
    Chang TI; Lim H; Park CH; Rhee CM; Moradi H; Kalantar-Zadeh K; Kang EW; Kang SW; Han SH
    Am J Kidney Dis; 2020 Aug; 76(2):224-232. PubMed ID: 32305207
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: A 5,693-patient cross-sectional analysis from Spain.
    Gorostidi M; Sarafidis PA; de la Sierra A; Segura J; de la Cruz JJ; Banegas JR; Ruilope LM;
    Am J Kidney Dis; 2013 Aug; 62(2):285-94. PubMed ID: 23689071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence and prognostic role of resistant hypertension in chronic kidney disease patients.
    De Nicola L; Gabbai FB; Agarwal R; Chiodini P; Borrelli S; Bellizzi V; Nappi F; Conte G; Minutolo R
    J Am Coll Cardiol; 2013 Jun; 61(24):2461-2467. PubMed ID: 23623908
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Usefulness of ambulatory blood pressure monitoring in chronic kidney disease: The moroccan experience.
    Asserraji M; Bouzerda A; Soukrate S; Maoujoud O; Belarbi M; Zemraoui N; Bendriss L; Khatouri A
    Saudi J Kidney Dis Transpl; 2019; 30(4):913-918. PubMed ID: 31464249
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and factors associated with resistant hypertension in a large health maintenance organization in Israel.
    Weitzman D; Chodick G; Shalev V; Grossman C; Grossman E
    Hypertension; 2014 Sep; 64(3):501-7. PubMed ID: 24958503
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of apparent treatment-resistant hypertension among individuals with CKD.
    Tanner RM; Calhoun DA; Bell EK; Bowling CB; Gutiérrez OM; Irvin MR; Lackland DT; Oparil S; Warnock D; Muntner P
    Clin J Am Soc Nephrol; 2013 Sep; 8(9):1583-90. PubMed ID: 23868902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.